Supplementary Figure 1 from Combined Targeting of Costimulatory (OX40) and Coinhibitory (CTLA-4) Pathways Elicits Potent Effector T Cells Capable of Driving Robust Antitumor Immunity
Authors:
- William L. RedmondWRWilliam L. Redmond
- Stefanie N. LinchSLStefanie N. Linch
- Melissa J. KasiewiczMKMelissa J. Kasiewicz
Open Access
- 3 April 2023
- other
- Published by American Association for Cancer Research (AACR)